Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:1033-1035
Published online before print January 31, 2008, doi: 10.1161/STROKEAHA.107.495499
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/3/1033    most recent
STROKEAHA.107.495499v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Cheung, E. Y.L.
Right arrow Articles by de Maat, M. P.M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheung, E. Y.L.
Right arrow Articles by de Maat, M. P.M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Coagulation
Right arrow Fibrinogen/fibrin
Right arrow Acute Cerebral Infarction
Right arrow Genetics of Stroke

(Stroke. 2008;39:1033.)
© 2008 American Heart Association, Inc.


Research Letters

Fibrinogen {gamma}' in Ischemic Stroke

A Case-Control Study

Elim Y.L. Cheung, MSc; Shirley Uitte de Willige, PhD; Hans L. Vos, PhD; Frank W.G. Leebeek, MD, PhD; Diederik W.J. Dippel, MD, PhD; Rogier M. Bertina, PhD Moniek P.M. de Maat, PhD

From the Departments of Hematology (E.Y.L.C., F.W.G.L., M.P.M.M.), and Neurology (D.W.J.D.), Erasmus University Medical Center, Rotterdam; and The Haemostasis and Thrombosis Research Center (S.U.W., H.L.V., R.M.B), Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

Correspondence to Moniek P.M. de Maat, Erasmus University Medical Center, Department of Hematology, Room L431, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. E-mail m.demaat{at}erasmusmc.nl

Abstract

Background and Purpose— To determine the contribution of fibrinogen {gamma}' levels and FGG haplotypes to ischemic stroke.

Methods— Associations between fibrinogen {gamma}' levels, fibrinogen {gamma}'/total fibrinogen ratio, and FGG haplotypes with the risk of ischemic stroke were determined in 124 cases and 125 controls.

Results— Fibrinogen {gamma}'/total fibrinogen ratio was higher in patients than in controls during the acute phase of the stroke and lower in the convalescent phase 3 months after the stroke. FGG haplotype 3 (H3) was associated with a reduced risk of ischemic stroke (odds ratio 0.60; 95% CI, 0.38 to 0.94), but not with the fibrinogen {gamma}'/total fibrinogen ratio. In contrast, FGG-H2 was associated with a decreased fibrinogen {gamma}'/total fibrinogen ratio, but not with risk of stroke.

Conclusions— Fibrinogen {gamma}'/total fibrinogen ratio is associated with ischemic stroke, especially in the acute phase of the disease. In addition, FGG-H3 haplotype appears to be protective against ischemic stroke.


Key Words: FGG haplotypes • fibrinogen {gamma}'/total fibrinogen ratios • ischemic stroke